Last edition
News about Global Pharma
Vertex Pharmaceuticals Secures Exclusive License for TreeFrog's C-Stem Technology
TreeFrog’s C-Stem™ platform is engineered to replicate the natural microenvironment, facilitating exponential growth of cells in three dimensions (3D).
Global Pharma | 24/04/2024 | By Abha | 642
Under the agreement, Cellares will streamline, automate, and transfer select Bristol Myers Squibb CAR T cell therapies onto its state-of-the-art manufacturing platform, the Cell Shuttle™.
Global Pharma | 24/04/2024 | By Abha | 706
Strand Life Sciences Develops Prenatal Genomic Diagnostics Portfolio
Strand Life Sciences has developed its prenatal screening and diagnostics portfolio with two breakthrough technologies: CNSeq (for identification of aneuploidies and copy number variations) and MaatriSeq (Non-Invasive Prenatal Screening).
Global Pharma | 24/04/2024 | By Aishwarya | 623
Incyte Acquires Escient Pharmaceuticals to Expand its Portfolio
Incyte has signed a definitive agreement with Escient Pharmaceuticals under which Incyte has agreed to acquire Escient, including EP262, a first-in-class, potent, highly selective, once-daily small molecule antagonist of Mas-related G protein-coupled receptor X2 (MRGPRX2) and EP547, a first-in-class oral MRGPRX4 antagonist.
Global Pharma | 24/04/2024 | By Aishwarya | 928
Molecular You Achieves Significant Milestone in Early detection of Pancreatic Cancer
Molecular You, a health technology company specializing in personalized medicine, has achieved a significant milestone in the early detection of pancreatic cancer.
Global Pharma | 23/04/2024 | By Manvi | 460
Expanse ICE Receives FDA Clearance for ICE Aspiration System
Peripheral thrombectomy, aimed at treating blood clots, is a vital intervention in vascular medicine, given that blood clots rank as the third most common vascular disease.
Global Pharma | 23/04/2024 | By Abha | 453
Innocan Pharma Submits Application for FDA Pre-IND Meeting for CBD Therapy to Combat Chronic Pain
The global pain therapeutics market, expected to surpass USD 100 billion by 2032, highlights the pressing need for effective alternatives to opioid-based treatments.
Global Pharma | 23/04/2024 | By Abha | 548
Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus
Eli Lilly has signed a definitive agreement with Nexus Pharmaceuticals wherein Lilly will be acquiring a manufacturing facility from Nexus.
Global Pharma | 23/04/2024 | By Aishwarya | 652
Panasonic and Shinobi Therapeutics to Develop iPS Cell Therapy Manufacturing Tech
Shinobi Therapeutics has joined hands with Panasonic Holdings Corp. and Kyoto University's Center for iPS Cell Research and Application (CiRA).
Global Pharma | 23/04/2024 | By Aishwarya | 229
PharmaLogic Opens New Radiopharmaceutical Production Facility in Cincinnati
PharmaLogic Holdings Corp. has opened its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
Global Pharma | 23/04/2024 | By Aishwarya | 994
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy